Inventor · disambiguated record
Richard Harkins
Also filed as: HARKINS RICHARD · HARKINS RICHARD N
9 granted patents·10 pending applications·79 citations·filing 1995–2014
87Inventor score
Files withBAYER SCHERING PHARMA AG7SCHERING AG5BAYER HEALTHCARE LLC2SCHERING AKTIENGESELLACHAFT2Bayer Schering Pharma1
Top patents by PatentIndex Score
19 records- 0192US7335748B2RG1 antibodies and uses thereofBAYER SCHERING PHARMA AG·Filed 2004·Granted Feb 26, 2008·46 cites·21 claims
- 0283US6682902B2DNA encoding a novel RG1 polypeptideSCHERING AG·Filed 2000·Granted Jan 27, 2004·16 cites·11 claims
- 0377US7611706B2RG1 antibodies and uses thereofBAYER SCHERING PHARMA AG·Filed 2007·Granted Nov 3, 2009·2 cites·12 claims
- 0477US7608263B2RG1 antibodies and uses thereofBAYER SCHERING PHARMA AG·Filed 2007·Granted Oct 27, 2009·2 cites·10 claims
- 0576US7307154B2DNA encoding a novel RG1 polypeptideBAYER SCHERING PHARMA AG·Filed 2003·Granted Dec 11, 2007·6 cites·5 claims
- 0665US2010081795A1Rg1 antibodies and uses thereofBayer Schering Pharma·Filed 2009·Application pending·0 cites
- 0764US7893217B2Isolated human antibodies that bind epitopes on RG1BAYER SCHERING PHARMA AG·Filed 2007·Granted Feb 22, 2011·0 cites·12 claims
- 0864US7887804B2Methods for treating disease-states associated with RG1 using immunoconjugatesBAYER SCHERING PHARMA AG·Filed 2007·Granted Feb 15, 2011·0 cites·9 claims
- 0957US8882484B2Methods and compositions for production of recombinant protein in HBX-expressing mammalian cellsJIN FANG·Filed 2009·Granted Nov 11, 2014·0 cites·13 claims
- 1057US2015044768A1Methods and compositions for production of recombinant protein in hbx-expressing mammalian cellsBAYER HEALTHCARE LLC·Filed 2014·Application pending·0 cites
- 1155US2004152139A1DNA encoding a novel RG1 polypeptideSCHERING AG·Filed 2003·Application pending·0 cites
- 1250US2011112022A1Factor VIII Muteins with Reduced ImmonugenicityBAYER HEALTHCARE LLC·Filed 2009·Application pending·0 cites
- 1349US2011020925A1New modulating molecules for an improved regulated expression systemBAYER SCHERING PHARMA AG·Filed 2008·Application pending·0 cites
- 1445US2007179113A1GM-CSF gene therapy for Crohn's disease using an improved regulated expression systemSCHERING AKTIENGESELLACHAFT·Filed 2007·Application pending·0 cites
- 1542US2008076729A1Interferon-beta gene therapy using an improved, regulated expression systemSCHERING AKTIENGESELLACHAFT·Filed 2007·Application pending·0 cites
- 1641US2006281703A1Treatment of disease using an improved regulated expression systemSCHERING AG·Filed 2006·Application pending·0 cites
- 1741US2006292609A1Interferon-beta gene therapy using an improved, regulated expression systemSCHERING AG·Filed 2006·Application pending·0 cites
- 1834US2012302492A1Antibody Mimetic ScaffoldsHARKINS RICHARD·Filed 2010·Application pending·0 cites
- 1933US5840687AModified ligands for receptor tyrosine kinasesSCHERING AG·Filed 1995·Granted Nov 24, 1998·7 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Richard Harkins files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →